Paper read to joint meeting of Sections of Ophthalmology and Paediatrics, 12 February 1987 0141·0768/88/ 040220-Q41$02.00/0 (C) 1988 The Royal Society of Medicine Retinoblastoma: a hereditary tumour Retinoblastoma (Rb) is an intraocular tumour affecting 1 : 20 000 young children each year'. Most cases are diagnosed before the age of 5 years and rarely occur after the age of 11. If tumours remain within the confines of the eye, Rb has the best prognosis of all childhood cancers; once extraocular spread has occurred, however, it is lethal. Death may result from meningeal involvement after direct spread down the optic nerve or from distant metastases following choroid invasion or extrascleral extension.
Most cases of Rb are apparently sporadic, but a significant proportion (25-40%) are familial! and inheritance follows an autosomal dominant mode with high penetrance (Figure 1 ). The hereditary cases are usually bilateral, multifocal and have an earlier age of onset when compared with the sporadic cases, which tend to be unifocal and unilateral. These observations led Knudson-to postulate a 'two-hit' hypothesis for the development ofRb and other hereditary cancers. Knudson assumed that Rb behaves as a recessive trait at the cellular level (otherwise all retinal cells would give rise to tumours, which is not the case), and that tumour development requires mutations in both normal counterparts of the gene. In familial cases the first mutation is inherited, and consequently only one additional mutation -the so-called 'second hit' -is required for tumour development.
Clearly, therefore, it is only a predisposition to tumour development which is inherited, but the chance of a single second event occurring is high. Empirical observation has shown that the frequency with which this second event occurs -the penetrance -is 90%1; only 9 times out of 10 will individuals who inherit the predisposition gene developthe tumour. In sporadic cases both mutations must occur as random postzygotic events: the chances of this are relatively low and consequently these tumours are associated with a longer latency period. The mean age of tumour presentation is 18 months for sporadic tumours compared with 10 months for hereditary cases. Since the development of multiple tumours at different sites is unlikely to occur by chance, it is generally accepted that all bilateral cases represent hereditary forms ofthe tumour, the incidence of which may be up to 50% in Britain. The reverse, however, is not always the case since, in our study", several familial cases have been observed which are only affected unilaterally. This is an important fact when formulating a screening/counselling programme for the children of Rb survivors.
Clinical aspects: the need for prenatal diagnosis The hereditary nature of many cases of Rb means that all siblings and children of Rb patients are screened regularly during the first 5 years of life. The examination takes the form ofindirect ophthalmoscopy under general anaesthesia, four times a year in the first two years, three times in the next year and twice a year until the age of 5. A yearly visit is recommended for those between 6 and 11 years, though their examinations are not under anaesthetic. This programme is traumatic to the patient.
Early diagnosis means that local conservative treatment by photocoagulation, cryosurgery, or cobalt plaque radiotherapy, may be possible. These procedures locally destroy the tumour without significantly affecting surrounding tissue. Therefore, depending on where the tumour occurs in the retina, it may be possible to save the individual's sight. More advanced tumours require more drastic treatment such as external beam irradiation, to which Rb has been shown to be particularly sensitive. External beam irradiation is not without risk and commonly produces bone and/or tissue facial asymmetry, dryness of the eyes and cataracts; very occasionally, second, nonocular tumours develop within the irradiated field and some of these may be radiation.induced. The most drastic treatment is to remove the eye.
Children of individuals with hereditary Rb have a 50% chance ofinheriting the predisposition gene, since it is carried on only one chromosome. Consequently, only half of the children being screened at present actually need serial examination but, because detection of tumours is the only reliable way of distinguishing hereditary from non-hereditary cases, there is currently no alternative to screening them all. This requirement adds an extra load to already overstretched hospital services. A substantial proportion of children with genetic Rb will subsequently develop a second, nonocular tumour. These tumours are usually bone or soft tissue sarcomas with a relatively poor prognosis for survival". These may occur outside the irradiated field and also in individuals who have not received radiotherapy or chemotherapy. The availability of a reliable test for screening fetuses and infants for the predisposition to tumour development would allow resources to be focused on those children who really need them. ) in the first generation was not available for analysis but must have been carrying the 2-allele since the other parent is homozygous for the I-allele and both children are heterozygous . In the third generation the affected child has inherited the 2-allele from the father whereas the unaffected child has inherited the I-allele. Both children receive a J-allele from their mother. This pedigree demonstrates that the chromosome carrying the 2-allele is also carrying the Rb predisposition gene ESD levels has proved to be a quick and objective means of identifying deletion carriers? and, in some cases, only after conventional chromosome analysis has proved inadequate". The in vitro enzyme assay can be carried out on red blood celllysates and, in our own survey of 400 patients, we have identified 16 deletion carriers of which 6 had not previously been diagnosed. In these 6 cases the deletions were very small and the patients were otherwise phenotypically normal and are, therefore, capable of transmitting the deletion to their children. Sizeable chromosome deletions are, however, only present in 10% of the hereditary cases of retinoblastoma, the remainder being transmitted as an autosomal dominant mutation. The location of the gene responsible for the nondeletion hereditary cases has also been localized to region 13q14 using standard linkage studies.
Linkage studies: esterase-D The esterase-D (ESD) protein has two electrophoretic variants, type 1 and type 2 8 • The close proximity of the ESD and Rb loci means that the ESD variants (polymorphic alleles) can be used to track the inheritance of the Rb predisposition locus (Figure 3 ). This analysis can only be used confidently for prenatal diagnosis ifthere is no significant genetic recombination between Rb and ESD. Several groups have analysed the linkage relationships between these two loci and in no case has a recombination event been recorded 9 -12 • Statistically, using the ESD polymorphism, prenatal diagnosis of Rb carriers will be COrrect 94 times out of 100 12 •. As more data accumulate, the confidenceof this prediction will undoubtedly increase. The use of this or any polymorphism, however, depends on the relative frequency of the alleles being used. As shown in Figure 3 , in order to track the Rb locus, it must be possible to distinguish between the two copies of chromosome 13 in the transmitting affected parent, i.e, they must be heterozygous at the poly. morphic locus. In the UK, for example, only 17% of the population are heterozygotes for the ESD protein polymorphism because of the low frequency of the 
Localization of the Rb predisposition gene
For those patients with hereditary Rb, there are now ways of following the inheritance of the predisposition gene and predicting who is at risk, in the absence of any knowledge about the function of the gene. This process is called 'gene tracking' and requires that the chromosomal location of the gene being tracked is known. Analysis of a small group of Rb patients carrying constitutional chromosome deletions provided the first clues to the location of the Rb gene.
The first case ofan Rb-associated chromosome deletion was reported in 1963 5 ; since then there have been over 100 such reports. In all cases the deletion is on the long arm of chromosome 13. Although the extent ofthese deletions varies (Figure 2 ), all or part of region 13q14 is always missing. These are constitutional chromosome deletions, present in every cell in the body, yet the patients only develop Rb. This suggests that the genetic locus which predisposes to tumour development is located in region 13q14. These deletions involve only one homologue and constitute the first hit; a second mutation is still needed for tumour development. Patients with larger deletions often have many other congenital abnormalities including mental retardation. Patients with small deletions usually have no phenotypic consequences other than Rb.
Using 2-allele I 2 • Consequently prenatal diagnosis using this polymorphism is available only to one in 7 families'".
Application of recombinant-DNA technology: the future If the remaining 83% of families are to be offered prenatal diagnosis, it is clear that other, more generally applicable tests are required. No other genes with polymorphic products have been identified in region 13q14, but natural variations in the nucleotide sequence of the DNA in that region are now being exploited to provide a means of tracking the Rb gene in families. Identification of variations in the DNA sequence depends on the action of a special class of enzymes -restriction enzymes -which recognize specific DNA sequences and cut the DNA at that point. When isolated, total human DNA is cut with these enzymes, and a heterogeneous population of restriction fragments is produced, each with its own characteristic length -restriction fragment lengths (RFL).
Natural variation in DNA sequence between individuals, such that new restriction sites are created 
Weakly cross-hybridizing bands can be seen below the main bands and should be ignored in this example. The affected individual in the first generation is heterozygous, showing both upper and lower bands on the autoradiograph (below).
All ofthe affected children in the second generation are also heterozygotes, whereas the unaffected child is homozygous for the lower band. The disease locus is therefore segregating with the upper band. In the third generation the only affected child is also heterozygous, i.e. has inherited the upper band. In the fourth generation the affected child is homozygous for the upper band, one allele being contributed by the father and one by the mother who, in this case, is alsoheterozygous. The upper band itself, therefore, is not responsible for the predisposition, but is being used to track the inheritance in blood relatives of the initial affected transmitting individual or old ones destroyed, will cause variations -polymorphisms -in the size of RFLs. Cloned DNA sequences (probes) from the region of interest can then be used to identify these restriction fragment length polymorphisms (RFLPs). The exact way in which this occurs is beyond the scope of this article, but has been described in detail elsewhera'", In essence, a combination of DNA reassociation techniques and autoradiography produces bands on an autoradiograph <Figure4). In this way, transmitting individuals can be identified who are heterozygous for the alleles of the RFLP and the predisposition gene can again be tracked through the family.
The application of DNA probes is still in its early stages, but the ESD gene has now been cloned 14, as has a gene with some of the properties expected of the Rb gene itself'", From these genes it will eventually be possible to isolate a variety of closely linked probes with different characteristics which can be applied to the prenatal diagnosis of Rb. It is not unrealistic to believe that eventually it will be possible to offer almost all Rb families prenatal diagnosis.
Conclusion
At present, therefore, it is possible to diagnose chromosome deletion carriers using ESD quantitation and also to follow the inheritance of the predisposition to Rb in a proportion of families. We have recently shown that both quantitiative and qualitative analysis of the ESD enzyme can be carried out on samples derived from the chorionic villus (CV)12 as well as cultured CV samples. The CV tissue is produced by the fetus and destined to become the placenta. Most importantly, CV samples can be obtained in the first trimester of pregnancy, after only 6-8 weeks. Thus, a diagnosis can be made early in pregnancy compared with the 18-20 weeks which must elapse before fetal blood samples can be taken. The same CV samples could be used to prepare DNA which can be used for carrier detection using DNA probes as described above. We are, therefore, moving rapidly towards the time when it will be possible to offer prenatal diagnosis to all familial cases of Rb. A remaining challenge will be to determine the nature of the genetic changes which occur within the Rb predisposition gene leading to abnormal development ofthe retina and consequently tumour development. It may then be possible to determine whether isolated cases of Rb are truly sporadic or the beginning of a new hereditary line.
